会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • PPAR 작용 조절 질환의 예방, 개선 또는 치료용 조성물
    • 用于预防,改善或治疗由PPAR治疗控制的疾病的组合物
    • KR1020130083427A
    • 2013-07-22
    • KR1020130080351
    • 2013-07-09
    • 한국과학기술연구원
    • 김수남이우정함정엽정유정황예란전영식윤구
    • A61K31/045A61K31/122A61K31/05A61P3/10
    • PURPOSE: A composition for preventing, treating, or alleviating peroxisome proliferator-activated receptor (PPAR) action regulatory diseases is provided to promote PPAR activation and to prevent, treat, or alleviate the diseases including obesity, metabolic diseases, and cardiovascular diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating PPAR action regulator diseases selected among diabetes, obesity, hyperinsulinemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, artery scleroma, and combination thereof contains a compound of chemical formula 1 or 2, or a pharmaceutically acceptable salt or a solvate thereof. A composition for health functional foods for preventing or treating the diseases contains the compound, the pharmaceutically acceptable salt, or the solvate.
    • 目的:提供一种预防,治疗或减轻过氧化物酶体增殖物激活受体(PPAR)作用调节性疾病的组合物,用于促进PPAR活化并预防,治疗或减轻包括肥胖,代谢疾病和心血管疾病在内的疾病。 构成:用于预防或治疗选自糖尿病,肥胖症,高胰岛素血症,高脂血症,高胆固醇血症,高甘油三酯血症,动脉硬化及其组合的PPAR活性调节剂疾病的药物组合物含有化学式1或2的化合物或其药学上可接受的盐或 其溶剂合物。 用于预防或治疗疾病的健康功能性食品的组合物含有化合物,药学上可接受的盐或溶剂合物。
    • 7. 发明公开
    • PPAR 작용 조절 질환의 예방, 개선 또는 치료용 조성물
    • 用于预防,改善或治疗由PPAR治疗控制的疾病的组合物
    • KR1020130047458A
    • 2013-05-08
    • KR1020110112506
    • 2011-10-31
    • 한국과학기술연구원
    • 김수남이우정함정엽정유정황예란전영식윤구
    • A61K36/8984A61K31/045A61K31/047A61P3/04
    • A61K36/8984A61K31/047A61K31/09A61K2236/333Y10S514/866Y10S514/909
    • PURPOSE: A composition containing Dendrobium moniliforme is provided to prevent, relieve, or treat PPAR activation regulation-related diseases including obesity, metabolic diseases, and cardiovascular diseases. CONSTITUTION: A composition for preventing or treating PPAR activation regulation-related diseases contains Dendrobium moniliforme as an active ingredient. A composition for health functional food for preventing or treating PPAR activation regulation-related diseases contains Dendrobium moniliforme as an active ingredient. Dendrobium moniliforme is used as pulverized Dendrobium moniliforme, a dried material thereof, or a crude extract prepared by using a solvent which is selected from water, C1-C4 alcohol, and a combination thereof. The C1-C4 alcohol is methanol or ethanol. Dendrobium moniliforme is also used as a fraction which is prepared from the crude extract using n-hexane, methylene chloride, or ethyl acetate. [Reference numerals] (AA) Relative value(%); (BB) No treatment group, Troglitazone; (CC) Example ; (DD) Example ; (EE) Example n-Hx; (FF) Example MC; (GG) Example EA; (HH) Example fr2; (II) Example fr3; (JJ) Example fr2-2; (KK) Example fr2-5; (LL) Example compound 1; (MM) Example compound 2; (NN) Example compound 3; (OO) Example compound 4
    • 目的:提供含有石斛仁的组合物,以预防,缓解或治疗PPAR活化调节相关疾病,包括肥胖,代谢疾病和心血管疾病。 构成:用于预防或治疗PPAR活化调节相关疾病的组合物含有石斛石斛作为活性成分。 用于预防或治疗PPAR活化调节相关疾病的健康功能性食品的组合物含有石斛兰作为活性成分。 石斛石斛被用作粉状石斛,其干燥物,或使用选自水,C1-C4醇及其组合的溶剂制备的粗提取物。 C1-C4醇是甲醇或乙醇。 石斛也用作由粗提取物使用正己烷,二氯甲烷或乙酸乙酯制备的级分。 (附图标记)(AA)相对值(%); (BB)无治疗组,曲格列酮; (CC)实施例<1-1>; (DD)实施例<1-2>; (EE)实施例<2> n-Hx; (FF)实施例<2> MC; (GG)实施例 EA; (HH)实施例<3> fr2; (II)实施例<3> fr3; (JJ)实施例<3> fr2-2; (KK)实施例<3> fr2-5; (LL)实施例<3>化合物1; (MM)实施例3化合物2; (NN)实施例3化合物3; (OO)实例<3>化合物4